Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.7001
-0.2999 (-29.99%)
At close: Oct 20, 2026

Vaccinex Revenue

In the year 2024, Vaccinex had annual revenue of $601.00K with 5.44% growth. Vaccinex had revenue of $213.00K in the quarter ending December 31, 2024. That makes Vaccinex the 44,296th largest company in the world by revenue and 6,279th in the United States.

Revenue
601.00K
Revenue Growth
+5.44%
P/S Ratio
3.12
Revenue / Employee
24.04K
Employees
27
Market Cap
1.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024601.00K31.00K5.44%
Dec 31, 2023570.00K295.00K107.27%
Dec 31, 2022275.00K-625.00K-69.44%
Dec 31, 2021900.00K275.00K44.00%
Dec 31, 2020625.00K102.00K19.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CASI Pharmaceuticals20.11M
International Stem Cell9.51M
BioAtla8.50M
Pacific Software2.40M
GPL Holdings376.54K
Enzolytics46.59K
Affymax42.00K
Revenue Rankings